Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial
暂无分享,去创建一个
J. Williamson | P. Whelton | Joni K. Snyder | K. Sink | M. Rocco | D. Reboussin | Mahboob Rahman | S. Oparil | C. Lewis | P. Kimmel | Lawrence J. Fine | J. Cutler | W. Cushman | A. Cheung | G. Chelune | C. Davatzikos | R. Bryan | S. Rapp | C. Moy | A. Auchus | M. Crowe | V. Wadley | G. Erus | L. Launer | L. Nichols | J. Martindale-Adams | D. Weiner | K. Johnson | C. Wright | A. Lerner | N. Pajewski | P. Ogrocki | B. Sachs | M. Hsieh | I. Nasrallah | L. Coker | S. Gaussoin | Valerie Wilson | M. Supiano | M. Tamura | C. Still | Jennifer Walker | L. Desiderio | A. Cheung | Darrin Harris | N. Woolard | K. Johnson | Maryjo L. Cleveland | J. Wright | J. Walker | Cora E. Lewis | C. Wright | S. Rapp | Michael G. Crowe | Meng-Kang Hsieh
[1] M. Hall. National Heart, Lung, and Blood Institute , 2020, The Grants Register 2021.
[2] Wilbert S Aronow,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Hypertension.
[3] J. Williamson,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Hypertension.
[4] A. Davey,et al. Clinical Trials of Blood Pressure Lowering and Antihypertensive Medication: Is Cognitive Measurement State-of-the-Art? , 2018, American journal of hypertension.
[5] K. Sink,et al. Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial , 2018, Journal of the American Geriatrics Society.
[6] Ronald C. Petersen,et al. Practice guideline update summary: Mild cognitive impairment , 2018, Neurology.
[7] H Steven Wiley,et al. How low can you go? , 2018, eLife.
[8] James R. Powell,et al. Effect of Intensive Blood‐Pressure Treatment on Patient‐Reported Outcomes , 2017, The New England journal of medicine.
[9] Marc Delord,et al. Multiple imputation for competing risks regression with interval-censored data , 2016 .
[10] Lenore J Launer,et al. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. , 2016, JAMA.
[11] Jackson T. Wright,et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.
[12] Enrico Mossello,et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. , 2015, JAMA internal medicine.
[13] O. Hanon,et al. Antihypertensive Drugs, Prevention of Cognitive Decline and Dementia: A Systematic Review of Observational Studies, Randomized Controlled Trials and Meta-Analyses, with Discussion of Potential Mechanisms , 2015, CNS Drugs.
[14] Walter T Ambrosius,et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) , 2014, Clinical trials.
[15] Michael E. Miller,et al. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. , 2014, JAMA internal medicine.
[16] A. Wimo,et al. The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.
[17] M. Özkaya,et al. Action to Control Cardiovascular Risk in Diabetes , 2013 .
[18] M. Espeland,et al. Ascertaining dementia‐related outcomes for deceased or proxy‐dependent participants: an overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol , 2012, International journal of geriatric psychiatry.
[19] Nick C Fox,et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[20] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[21] T. Ogihara,et al. Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study , 2010, Hypertension.
[22] Carol Brayne,et al. Age, neuropathology, and dementia. , 2009, The New England journal of medicine.
[23] Chiu-Hsieh Hsu,et al. Nonparametric comparison of two survival functions with dependent censoring via nonparametric multiple imputation , 2009, Statistics in medicine.
[24] John M. Abowd,et al. Multiple Imputation , 2009, Encyclopedia of Database Systems.
[25] D. Perl,et al. Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. , 2008, Archives of neurology.
[26] C. Bulpitt,et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.
[27] Li-sheng Liu,et al. Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.
[28] David A. Bennett,et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.
[29] U. Lindblad,et al. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older , 2007, Aging clinical and experimental research.
[30] Chiu-Hsieh Hsu,et al. Survival analysis using auxiliary variables via non‐parametric multiple imputation , 2006, Statistics in medicine.
[31] Li-sheng Liu,et al. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients , 2005, Journal of hypertension.
[32] L. Lindholm,et al. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis , 2005, The Lancet.
[33] B. Winblad,et al. The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.
[34] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[35] David Wechsler,et al. Wechsler Memory scale. , 2005 .
[36] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[37] Jan A Staessen,et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002, Archives of internal medicine.
[38] H. Soininen,et al. Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.
[39] J. Price,et al. Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.
[40] Jan A Staessen,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.
[41] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[42] L. Thal,et al. A validation study of the Dementia Questionnaire. , 1994, Archives of neurology.
[43] J. Breitner,et al. Detection of dementia in the elderly using telephone screening of cognitive status , 1993 .
[44] T. Kurosaki,et al. Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.